Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis

Annals of Otology, Rhinology and Laryngology

Volumn 110, Issue 11, 2001, Pages 1035-1040

  Ohwatari, Ryuichiro ^a   Inuyama, Yukio ^a   Fukuda, Satoshi ^a   Onoé, Kazunori ^a   Iwabuchi, Kazuya ^a   Nishihira, Jun ^a  

^a NONE   (Japan)

Author keywords

C ANCA; Macrophage migration inhibitory factor; Relapsing polychondritis; Vasculitis; Wegener's granulomatosis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; LABORATORY TEST; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RELAPSING POLYCHONDRITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; WEGENER GRANULOMATOSIS;

EID: 0035149360     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940111001108     Document Type: Article

References (26)

1. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
2. Reevaluation of the biological functions of macrophage migration inhibitory factor (MIF) within and beyond the immune system
3. Novel pathophysiological aspects of macrophage migration inhibitory factor
4. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis
5. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice
6. Wegener's granulomatosis. Pathology and review of the literature
7. Limited forms of angiitis and granulomatosis of Wegener's type
8. Auto-antibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis
9. Relapsing polychondritis. Survival and predictive role of early disease manifestations
10. Specificity of antibodies to type II collagen in rheumatoid arthritis
11. Polychondritis
12. Relapsing polychondritis - Report of ten cases
13. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharides
14. MIF as a glucocorticoid-induced modulator of cytokine production
15. Testing with antineutrophil cytoplasmic antibody to diagnose Wegener granulomatosis
16. Immunopathology of ANCA-associated vasculitis
17. Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis
18. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
19. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis
20. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis
21. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides
22. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints
23. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
24. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
25. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies
26. Protection from septic shock by neutralization of macrophage migration inhibitory factor